Rezolute added to russell microcap® index

Redwood city, calif., june 28, 2021 (globe newswire) -- rezolute, inc. (nasdaq: rzlt), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases related to chronic glucose imbalance, has been added to the russell microcap® index at the conclusion of the 2021 russell indexes annual reconstitution, effective after the us market opens on june 28.

RZLT Ratings Summary

RZLT Quant Ranking